Literature DB >> 3905219

Serum beta 2-microglobulin in systemic sclerosis.

L Pagano, S Paoletti, G Afa, R Marra, A Garcovich, B Bizzi.   

Abstract

The role of beta 2 microglobulin (beta 2-m) in Systemic Sclerosis (SS) has been evaluated. Twenty-four female patients have been examined: 15 of them were affected by acrosclerosis (Group 1) and 9 of them by diffuse sclerosis (Group 2). 46.6% of Group 1 and 44.4% of Group 2 had values significantly higher than normal controls. (P less than 0.01 and P less than 0.005 respectively). The authors deal with the validity of the use of B2-m as index of inflammatory activity of the disease.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3905219     DOI： 10.1007/bf02031609

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


  18 in total

1.  Production of beta 2-microglobulin by normal and malignant human cell lines and peripheral lymphocytes.

Authors:  K Nilsson; P E Evrin; K I Welsh
Journal:  Transplant Rev       Date:  1974

2.  The interchange of derivatives of human B2-microglobulin in HLA alloantigens.

Authors:  P J Ward; A R Sanderson
Journal:  Immunology       Date:  1983-01       Impact factor: 7.397

3.  Beta2 microglobulin and lymphocytic infiltration in Sjögren's syndrome.

Authors:  J P Michalski; T E Daniels; N Talal; H M Grey
Journal:  N Engl J Med       Date:  1975-12-11       Impact factor: 91.245

4.  Beta 2-microglobulin and its binding activity in serum from patients with SLE.

Authors:  P E Evrin; T Ström
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

5.  2 -Microglobulin--a free immunoglobulin domain.

Authors:  P A Peterson; B A Cunningham; I Berggård; G M Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1972-07       Impact factor: 11.205

Review 6.  beta 2-Microglobulin in clinical medicine.

Authors:  F A Karlsson; L Wibell; P E Evrin
Journal:  Scand J Clin Lab Invest Suppl       Date:  1980

7.  Elevated salivary and synovial fluid beta2-microglobulin in Sjogren's syndrome and rheumatoid arthritis.

Authors:  N Talal; H M Grey; N Zvaifler; J P Michalski; T E Daniels
Journal:  Science       Date:  1975-03-28       Impact factor: 47.728

8.  Serum beta 2-microglobulin in malignant lymphoma.

Authors:  H Hagberg; A Killander; B Simonsson
Journal:  Cancer       Date:  1983-06-15       Impact factor: 6.860

9.  Serum beta2 microglobulin and survival duration in multiple myeloma: a simple reliable marker for staging.

Authors:  R Bataille; B G Durie; J Grenier
Journal:  Br J Haematol       Date:  1983-11       Impact factor: 6.998

10.  Endothelial injury in scleroderma.

Authors:  M B Kahaleh; G K Sherer; E C LeRoy
Journal:  J Exp Med       Date:  1979-06-01       Impact factor: 14.307
View more
  1 in total

1.  Soluble markers of B cell activation suggest a role of B cells in the pathogenesis of systemic sclerosis-associated pulmonary arterial hypertension.

Authors:  Sébastien Sanges; Thomas Guerrier; Alain Duhamel; Lucile Guilbert; Carine Hauspie; Alexis Largy; Maïté Balden; Céline Podevin; Guillaume Lefèvre; Manel Jendoubi; Silvia Speca; Éric Hachulla; Vincent Sobanski; Sylvain Dubucquoi; David Launay
Journal:  Front Immunol       Date:  2022-07-29       Impact factor: 8.786
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.